Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
EditorialEditor’s Page

More Unacceptable Denials: Now It’s PSMA-Targeted PET/CT Imaging

Johannes Czernin, Thaiza Adams and Jeremie Calais
Journal of Nuclear Medicine July 2022, 63 (7) 969-970; DOI: https://doi.org/10.2967/jnumed.121.264374
Johannes Czernin
1David Geffen School of Medicine at UCLA, Los Angeles, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thaiza Adams
1David Geffen School of Medicine at UCLA, Los Angeles, California; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremie Calais
2Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 7 969-970
DOI 
https://doi.org/10.2967/jnumed.121.264374
PubMed 
35772954

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online June 30, 2022.

Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Application of next-generation imaging in biochemically recurrent prostate cancer
    Judd W. Moul, Neal D. Shore, Kenneth J. Pienta, Johannes Czernin, Martin T. King, Stephen J. Freedland
    Prostate Cancer and Prostatic Diseases 2024 27 2
  • The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging
    Hae Lin Cho, Subha Perni, Anthony V. D’Amico, Kosj Yamoah, Edward Christopher Dee
    Prostate Cancer and Prostatic Diseases 2023 26 3
  • PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy
    Phillip H. Kuo, Jeremie Calais, Mike Crosby
    Targeted Oncology 2025

Article usage

Article usage: June 2022 to April 2025

AbstractFullPdf
Jun 2022027184
Jul 2022015611122
Aug 20220329111
Sep 2022019671
Oct 2022020439
Nov 2022011050
Dec 2022038119
Jan 2023041450
Feb 20230397283
Mar 20230428570
Apr 20230303379
May 20230291400
Jun 20230272403
Jul 20230291378
Aug 20230392303
Sep 20230317382
Oct 20230201126
Nov 2023018743
Dec 2023017875
Jan 2024026678
Feb 2024030438
Mar 2024021945
Apr 2024017361
May 2024016157
Jun 2024010941
Jul 2024017935
Aug 2024014923
Sep 202408837
Oct 202409622
Nov 202409414
Dec 2024012633
Jan 202509822
Feb 2025016132
Mar 2025010328
Apr 2025012843
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (7)
Journal of Nuclear Medicine
Vol. 63, Issue 7
July 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
More Unacceptable Denials: Now It’s PSMA-Targeted PET/CT Imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
More Unacceptable Denials: Now It’s PSMA-Targeted PET/CT Imaging
Johannes Czernin, Thaiza Adams, Jeremie Calais
Journal of Nuclear Medicine Jul 2022, 63 (7) 969-970; DOI: 10.2967/jnumed.121.264374

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
More Unacceptable Denials: Now It’s PSMA-Targeted PET/CT Imaging
Johannes Czernin, Thaiza Adams, Jeremie Calais
Journal of Nuclear Medicine Jul 2022, 63 (7) 969-970; DOI: 10.2967/jnumed.121.264374
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Funding Reductions Threaten the Future of Medical Innovation
  • Reflections on the Demand for PSMA- and SSTR-Targeted Radiopharmaceutical Therapies: Why We Were Wrong (and Why We Will Be Right Eventually)
  • The Costs to Our Patients
Show more Editor’s Page

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire